Hepatic Radioembolization as a Bridge to Liver Surgery
Treatment of oncologic disease has improved significantly in the last decades and in the future a vast majority of cancer types will continue to increase worldwide. As a result many patients are confronted with primary liver cancers or metastatic liver disease. Surgery in liver malignancies has stee...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00199/full |
id |
doaj-59db3dd1bcda46e187dc91fd8f36ded5 |
---|---|
record_format |
Article |
spelling |
doaj-59db3dd1bcda46e187dc91fd8f36ded52020-11-24T22:16:18ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2014-07-01410.3389/fonc.2014.00199104016Hepatic Radioembolization as a Bridge to Liver SurgeryArthur J.A.T. Braat0Julia E. Huijbregts1Quintus eMolenaar2Inne H.M. Borel Rinkes3Maurice A.A.J. van den Bosch4Marnix G.E.H. Lam5UMC UtrechtUMC UtrechtUMC UtrechtUMC UtrechtUMC UtrechtUMC UtrechtTreatment of oncologic disease has improved significantly in the last decades and in the future a vast majority of cancer types will continue to increase worldwide. As a result many patients are confronted with primary liver cancers or metastatic liver disease. Surgery in liver malignancies has steeply improved and curative resections are applicable in wider settings, leading to a prolonged survival. Simultaneously, radiofrequency ablation (RFA) and liver transplantation (LTx) have been applied more commonly in oncologic settings with improving results. To minimize adverse events in treatments of liver malignancies, locoregional minimal invasive treatments have made their appearance in this field, in which radioembolization (RE) has shown promising results in recent years with few adverse events and high response rates. We discuss several other applications of radioembolization for oncologic patients, other than its use in the palliative setting, whether or not combined with other treatments. This review is focused on the role of RE in acquiring patient eligibility for radical treatments, like surgery, RFA and LTx. Inducing significant tumor reduction can downstage patients for resection or, through attaining stable disease, patients can stay on the LTx waiting list. Hereby, RE could make a difference between curative of palliative intent in oncologic patient management. Prior to surgery, the future remnant liver volume might be inadequate in some patients. In these patients, forming an adequate liver reserve through RE leads to prolonged survival without risking postoperative liver failure and minimizing tumor progression while inducing hypertrophy. In order to optimize results, developments in procedures surrounding RE are equally important. Predicting the remaining liver function after radical treatment and finding the right balance between maximum tumor irradiation and minimizing the chance of inducing radiation-related complications are still challenges.http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00199/fullLiver NeoplasmsDosimetryRadioembolizationHepatobiliary imagingdownstagingbridge to transplantation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Arthur J.A.T. Braat Julia E. Huijbregts Quintus eMolenaar Inne H.M. Borel Rinkes Maurice A.A.J. van den Bosch Marnix G.E.H. Lam |
spellingShingle |
Arthur J.A.T. Braat Julia E. Huijbregts Quintus eMolenaar Inne H.M. Borel Rinkes Maurice A.A.J. van den Bosch Marnix G.E.H. Lam Hepatic Radioembolization as a Bridge to Liver Surgery Frontiers in Oncology Liver Neoplasms Dosimetry Radioembolization Hepatobiliary imaging downstaging bridge to transplantation |
author_facet |
Arthur J.A.T. Braat Julia E. Huijbregts Quintus eMolenaar Inne H.M. Borel Rinkes Maurice A.A.J. van den Bosch Marnix G.E.H. Lam |
author_sort |
Arthur J.A.T. Braat |
title |
Hepatic Radioembolization as a Bridge to Liver Surgery |
title_short |
Hepatic Radioembolization as a Bridge to Liver Surgery |
title_full |
Hepatic Radioembolization as a Bridge to Liver Surgery |
title_fullStr |
Hepatic Radioembolization as a Bridge to Liver Surgery |
title_full_unstemmed |
Hepatic Radioembolization as a Bridge to Liver Surgery |
title_sort |
hepatic radioembolization as a bridge to liver surgery |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2014-07-01 |
description |
Treatment of oncologic disease has improved significantly in the last decades and in the future a vast majority of cancer types will continue to increase worldwide. As a result many patients are confronted with primary liver cancers or metastatic liver disease. Surgery in liver malignancies has steeply improved and curative resections are applicable in wider settings, leading to a prolonged survival. Simultaneously, radiofrequency ablation (RFA) and liver transplantation (LTx) have been applied more commonly in oncologic settings with improving results. To minimize adverse events in treatments of liver malignancies, locoregional minimal invasive treatments have made their appearance in this field, in which radioembolization (RE) has shown promising results in recent years with few adverse events and high response rates. We discuss several other applications of radioembolization for oncologic patients, other than its use in the palliative setting, whether or not combined with other treatments. This review is focused on the role of RE in acquiring patient eligibility for radical treatments, like surgery, RFA and LTx. Inducing significant tumor reduction can downstage patients for resection or, through attaining stable disease, patients can stay on the LTx waiting list. Hereby, RE could make a difference between curative of palliative intent in oncologic patient management. Prior to surgery, the future remnant liver volume might be inadequate in some patients. In these patients, forming an adequate liver reserve through RE leads to prolonged survival without risking postoperative liver failure and minimizing tumor progression while inducing hypertrophy. In order to optimize results, developments in procedures surrounding RE are equally important. Predicting the remaining liver function after radical treatment and finding the right balance between maximum tumor irradiation and minimizing the chance of inducing radiation-related complications are still challenges. |
topic |
Liver Neoplasms Dosimetry Radioembolization Hepatobiliary imaging downstaging bridge to transplantation |
url |
http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00199/full |
work_keys_str_mv |
AT arthurjatbraat hepaticradioembolizationasabridgetoliversurgery AT juliaehuijbregts hepaticradioembolizationasabridgetoliversurgery AT quintusemolenaar hepaticradioembolizationasabridgetoliversurgery AT innehmborelrinkes hepaticradioembolizationasabridgetoliversurgery AT mauriceaajvandenbosch hepaticradioembolizationasabridgetoliversurgery AT marnixgehlam hepaticradioembolizationasabridgetoliversurgery |
_version_ |
1725790746371424256 |